Genetic variation in schizophrenia-risk-gene dysbindin 1 modulates brain activation in anterior cingulate cortex and right temporal gyrus during language production in healthy individuals

NeuroImage

Volumn 47, Issue 4, 2009, Pages 2016-2022

  Markov, V ^a,f   Krug, A ^b   Krach, S ^b   Whitney, C ^a,f   Eggermann, T ^a   Zerres, K ^a   Stocker T ^c,f   Shah, N J ^c,f   Nothen M M ^d   Treutlein, J ^e   Rietschel, M ^e   Kircher, T ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^f JARA Translational Brain Medicine

Author keywords

DTNBP1; fMRI; P1578; rs1018381; Verbal fluency

Indexed keywords

CYTOSINE; DYSBINDIN; THREONINE;

ADULT; ALLELE; ARTICLE; BRAIN FUNCTION; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; GERMANY; HAPLOTYPE MAP; HEMISPHERIC DOMINANCE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; LANGUAGE ABILITY; LANGUAGE PROCESSING; MALE; NORMAL HUMAN; PERSONALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RIGHT HEMISPHERE; RISK ASSESSMENT; SCHIZOPHRENIA; SEMANTICS; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE; TEMPORAL CORTEX; VERBAL BEHAVIOR; VOLUNTEER;

BRAIN MAPPING; CARRIER PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GYRUS CINGULI; HUMANS; LANGUAGE; MAGNETIC RESONANCE IMAGING; MALE; RISK FACTORS; SCHIZOPHRENIA; TEMPORAL LOBE; YOUNG ADULT;

EID: 67651030035     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.05.067     Document Type: Article

References (74)

1. Basho S., Palmer E.D., Rubio M.A., Wulfeck B., and Muller R.A. Effects of generation mode in fMRI adaptations of semantic fluency: paced production and overt speech. Neuropsychologia 45 (2007) 1697-1706
2. Benson M.A., Newey S.E., Martin-Rendon E., Hawkes R., and Blake D.J. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J. Biol. Chem. 276 (2001) 24232-24241
3. Blake D.J., Hawkes R., Benson M.A., and Beesley P.W. Different dystrophin-like complexes are expressed in neurons and glia. J. Cell Biol. 147 (1999) 645-658
4. Bokat C.E., and Goldberg T.E. Letter and category fluency in schizophrenic patients: a meta-analysis. Schizophr. Res. 64 (2003) 73-78
5. Boksman K., Theberge J., Williamson P., Drost D.J., Malla A., Densmore M., Takhar J., Pavlosky W., Menon R.S., and Neufeld R.W. A 4.0-T fMRI study of brain connectivity during word fluency in first-episode schizophrenia. Schizophr. Res. 75 (2005) 247-263
6. Buchanan T.W., Lutz K., Mirzazade S., Specht K., Shah N.J., Zilles K., and Jancke L. Recognition of emotional prosody and verbal components of spoken language: an fMRI study. Brain Res. Cogn. Brain Res. 9 (2000) 227-238
7. Burdick K.E., Hodgkinson C.A., Szeszko P.R., Lencz T., Ekholm J.M., Kane J.M., Goldman D., and Malhotra A.K. DISC1 and neurocognitive function in schizophrenia. Neuroreport 16 (2005) 1399-1402
8. Burdick K.E., Lencz T., Funke B., Finn C.T., Szeszko P.R., Kane J.M., Kucherlapati R., and Malhotra A.K. Genetic variation in DTNBP1 influences general cognitive ability. Hum. Mol. Genet. 15 (2006) 1563-1568
9. Burdick K.E., Goldberg T.E., Funke B., Bates J.A., Lencz T., Kucherlapati R., and Malhotra A.K. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr. Res. 89 (2007) 169-172
10. Cabeza R., and Nyberg L. Imaging cognition II: an empirical review of 275 PET and fMRI studies. J. Cogn. Neurosci. 12 (2000) 1-47
11. Chen Y.L., Chen Y.H., and Lieh-Mak F. Semantic verbal fluency deficit as a familial trait marker in schizophrenia. Psychiatry Res. 95 (2000) 133-148
12. Coney J., and Evans K.D. Hemispheric asymmetries in the resolution of lexical ambiguity. Neuropsychologia 38 (2000) 272-282
13. Coyle J.T. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell. Mol. Neurobiol. 26 (2006) 365-384
14. Crespo-Facorro B., Nopoulos P.C., Chemerinski E., Kim J.J., Andreasen N.C., and Magnotta V. Temporal pole morphology and psychopathology in males with schizophrenia. Psychiatry Res. 132 (2004) 107-115
15. DeLisi L.E. Speech disorder in schizophrenia: review of the literature and exploration of its relation to the uniquely human capacity for language. Schizophr. Bull 27 (2001) 481-496
16. Demonet J.F., Thierry G., and Cardebat D. Renewal of the neurophysiology of language: functional neuroimaging. Physiol. Rev. 85 (2005) 49-95
17. Donohoe G., Morris D.W., Clarke S., McGhee K.A., Schwaiger S., Nangle J.M., Garavan H., Robertson I.H., Gill M., and Corvin A. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study. Neuropsychologia 45 (2007) 454-458
18. Fletcher P.C., Frith C.D., Grasby P.M., Friston K.J., and Dolan R.J. Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia. J. Neurosci. 16 (1996) 7055-7062
19. Foldi N.S. Appreciation of pragmatic interpretations of indirect commands: comparison of right and left hemisphere brain-damaged patients. Brain Lang. 31 (1987) 88-108
20. Friston K.J., and Frith C.D. Schizophrenia: a disconnection syndrome?. Clin. Neurosci. 3 (1995) 89-97
21. Funke B., Finn C.T., Plocik A.M., Lake S., DeRosse P., Kane J.M., Kucherlapati R., and Malhotra A.K. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am. J. Hum. Genet. 75 (2004) 891-898
22. Goldberg T.E., Straub R.E., Callicott J.H., Hariri A., Mattay V.S., Bigelow L., Coppola R., Egan M.F., and Weinberger D.R. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology 31 (2006) 2022-2032
23. Gur R.E., Turetsky B.I., Cowell P.E., Finkelman C., Maany V., Grossman R.I., Arnold S.E., Bilker W.B., and Gur R.C. Temporolimbic volume reductions in schizophrenia. Arch. Gen. Psychiatry 57 (2000) 769-775
24. Hall J., Whalley H.C., Job D.E., Baig B.J., McIntosh A.M., Evans K.L., Thomson P.A., Porteous D.J., Cunningham-Owens D.G., Johnstone E.C., and Lawrie S.M. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat. Neurosci. 9 (2006) 1477-1478
25. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10, 40-68; image 45 (2005)
26. Henry J.D., and Crawford J.R. A meta-analytic review of verbal fluency deficits in schizophrenia relative to other neurocognitive deficits. Cognit. Neuropsychiatry. 10 (2005) 1-33
27. Indefrey P., and Levelt W.J. The spatial and temporal signatures of word production components. Cognition 92 (2004) 101-144
28. Kircher T., Whitney C., Krings T., Huber W., and Weis S. Hippocampal dysfunction during free word association in male patients with schizophrenia. Schizophr. Res. 101 (2008) 242-255
29. Kircher T.T., Liddle P.F., Brammer M.J., Williams S.C., Murray R.M., and McGuire P.K. Reversed lateralization of temporal activation during speech production in thought disordered patients with schizophrenia. Psychol. Med. 32 (2002) 439-449
30. Kirov G., Ivanov D., Williams N.M., Preece A., Nikolov I., Milev R., Koleva S., Dimitrova A., Toncheva D., O Donovan M.C., and Owen M.J. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol. Psychiatry 55 (2004) 971-975
31. Kuperberg G.R., Deckersbach T., Holt D.J., Goff D., and West W.C. Increased temporal and prefrontal activity in response to semantic associations in schizophrenia. Arch. Gen. Psychiatry 64 (2007) 138-151
32. Kuroki N., Shenton M.E., Salisbury D.F., Hirayasu Y., Onitsuka T., Ersner-Hershfield H., Yurgelun-Todd D., Kikinis R., Jolesz F.A., and McCarley R.W. Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: an MRI study. Am. J. Psychiatry 163 (2006) 2103-2110
33. Luciano M., Miyajima F., Lind P.A., Bates T.C., Horan M., Harris S.E., Wright M.J., Ollier W.E., Hayward C., Pendleton N., Gow A.J., Visscher P.M., Starr J.M., Deary I.J., Martin N.G., and Payton A. Variation in the dysbindin gene and normal cognitive function in three independent population samples. Genes Brain Behav. 8 (2009) 218-227
34. Markowitsch H.J. Which brain regions are critically involved in the retrieval of old episodic memory?. Brain Res. Brain Res. Rev. 21 (1995) 117-127
35. Mesulam M. Paralimbic (mesocortical) areas. In: MM M. (Ed). Principles of Behavioral and Cognitive Neurology (2000), Oxford University Press, New York, NY 49-54
36. Mitchell R.L., and Crow T.J. Right hemisphere language functions and schizophrenia: the forgotten hemisphere?. Brain 128 (2005) 963-978
37. Mitchell R.L., Elliott R., Barry M., Cruttenden A., and Woodruff P.W. The neural response to emotional prosody, as revealed by functional magnetic resonance imaging. Neuropsychologia 41 (2003) 1410-1421
38. Mutsuddi M., Morris D.W., Waggoner S.G., Daly M.J., Scolnick E.M., and Sklar P. Analysis of high-resolution HapMap of DTNBP1 (dysbindin) suggests no consistency between reported common variant associations and schizophrenia. Am. J. Hum. Genet. 79 (2006) 903-909
39. Numakawa T., Yagasaki Y., Ishimoto T., Okada T., Suzuki T., Iwata N., Ozaki N., Taguchi T., Tatsumi M., Kamijima K., Straub R.E., Weinberger D.R., Kunugi H., and Hashimoto R. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 13 (2004) 2699-2708
40. Ohnishi T., Hashimoto R., Mori T., Nemoto K., Moriguchi Y., Iida H., Noguchi H., Nakabayashi T., Hori H., Ohmori M., Tsukue R., Anami K., Hirabayashi N., Harada S., Arima K., Saitoh O., and Kunugi H. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 129 (2006) 399-410
41. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9 (1971) 97-113
42. Owen M.J., O Donovan M.C., and Gottesman I.I. Schizophrenia. In: McGuffin P., Owen M.J., and Gottesman I.I. (Eds). Psychiatric Genetics and Genomics (2002), Oxford Medical Publishers, Oxford 247-266
43. Owen M.J., Williams N.M., and O Donovan M.C. The molecular genetics of schizophrenia: new findings promise new insights. Mol. Psychiatry 9 (2004) 14-27
44. Ragland J.D., Moelter S.T., Bhati M.T., Valdez J.N., Kohler C.G., Siegel S.J., Gur R.C., and Gur R.E. Effect of retrieval effort and switching demand on fMRI activation during semantic word generation in schizophrenia. Schizophr. Res. 99 (2008) 312-323
45. Robertson D.A., Gernsbacher M.A., Guidotti S.J., Robertson R.R., Irwin W., Mock B.J., and Campana M.E. Functional neuroanatomy of the cognitive process of mapping during discourse comprehension. Psychol. Sci. 11 (2000) 255-260
46. Rossi A., Serio A., Stratta P., Petruzzi C., Schiazza G., Mancini F., and Casacchia M. Planum temporale asymmetry and thought disorder in schizophrenia. Schizophr. Res. 12 (1994) 1-7
47. Schaufelberger M., Senhorini M.C., Barreiros M.A., Amaro Jr. E., Menezes P.R., Scazufca M., Castro C.C., Ayres A.M., Murray R.M., McGuire P.K., and Busatto G.F. Frontal and anterior cingulate activation during overt verbal fluency in patients with first episode psychosis. Rev. Bras. Psiquiatr. 27 (2005) 228-232
48. Schwab S.G., Knapp M., Mondabon S., Hallmayer J., Borrmann-Hassenbach M., Albus M., Lerer B., Rietschel M., Trixler M., Maier W., and Wildenauer D.B. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 72 (2003) 185-190
49. Shenton M.E., Kikinis R., Jolesz F.A., Pollak S.D., LeMay M., Wible C.G., Hokama H., Martin J., Metcalf D., Coleman M., et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. A quantitative magnetic resonance imaging study. N. Engl. J. Med. 327 (1992) 604-612
50. Sitskoorn M.M., Aleman A., Ebisch S.J., Appels M.C., and Kahn R.S. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr. Res. 71 (2004) 285-295
51. Snitz B.E., Macdonald III A.W., and Carter C.S. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr. Bull. 32 (2006) 179-194
52. Sommer I.E., Ramsey N.F., and Kahn R.S. Language lateralization in schizophrenia, an fMRI study. Schizophr. Res. 52 (2001) 57-67
53. Sommer I.E., Ramsey N.F., Mandl R.C., and Kahn R.S. Language lateralization in female patients with schizophrenia: an fMRI study. Schizophr. Res. 60 (2003) 183-190
54. Sommer I.E., Ramsey N.F., Mandl R.C., van Oel C.J., and Kahn R.S. Language activation in monozygotic twins discordant for schizophrenia. Br. J. Psychiatry 184 (2004) 128-135
55. Spencer M.D., Moorhead T.W., McIntosh A.M., Stanfield A.C., Muir W.J., Hoare P., Owens D.G., Lawrie S.M., and Johnstone E.C. Grey matter correlates of early psychotic symptoms in adolescents at enhanced risk of psychosis: a voxel-based study. Neuroimage 35 (2007) 1181-1191
56. Stefanis N.C., Trikalinos T.A., Avramopoulos D., Smyrnis N., Evdokimidis I., Ntzani E.E., Ioannidis J.P., and Stefanis C.N. Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol. Psychiatry 62 (2007) 784-792
57. Straub R.E., Jiang Y., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., Cesare A.J., Gibberman A., Wang X., O Neill F.A., Walsh D., and Kendler K.S. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 71 (2002) 337-348
58. Szöke A., Schürhoff F., Mathieu F., Meary A., Ionescu S., and Leboyer M. Tests of executive functions in first-degree relatives of schizophrenic patients: a meta-analysis. Psychol. Med. 35 (2004) 771-782
59. Talairach, J., Tournoux, P., 1988. Co-planar stereotaxic atlas of the human brain. Thieme, New York.
60. Talbot K., Eidem W.L., Tinsley C.L., Benson M.A., Thompson E.W., Smith R.J., Hahn C.G., Siegel S.J., Trojanowski J.Q., Gur R.E., Blake D.J., and Arnold S.E. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest. 113 (2004) 1353-1363
61. Tang J.X., Zhou J., Fan J.B., Li X.W., Shi Y.Y., Gu N.F., Feng G.Y., Xing Y.L., Shi J.G., and He L. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol. Psychiatry 8 (2003) 717-718
62. Tosato S., Ruggeri M., Bonetto C., Bertani M., Marrella G., Lasalvia A., Cristofalo D., Aprili G., Tansella M., Dazzan P., Diforti M., Murray R.M., and Collier D.A. Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144B (2007) 647-659
63. Van Den Bogaert A., Schumacher J., Schulze T.G., Otte A.C., Ohlraun S., Kovalenko S., Becker T., Freudenberg J., Jonsson E.G., Mattila-Evenden M., Sedvall G.C., Czerski P.M., Kapelski P., Hauser J., Maier W., Rietschel M., Propping P., Nothen M.M., and Cichon S. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am. J. Hum. Genet. 73 (2003) 1438-1443
64. van den Oord E.J., Sullivan P.F., Jiang Y., Walsh D., O Neill F.A., Kendler K.S., and Riley B.P. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol. Psychiatry 8 (2003) 499-510
65. Vogt B.A., Berger G.R., and Derbyshire S.W. Structural and functional dichotomy of human midcingulate cortex. Eur. J. Neurosci. 18 (2003) 3134-3144
66. Voight B.F., Kudaravalli S., Wen X., and Pritchard J.K. A map of recent positive selection in the human genome. PLoS Biol. 4 (2006) e72
67. Weickert C.S., Rothmond D.A., Hyde T.M., Kleinman J.E., and Straub R.E. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr. Res. 98 (2008) 105-110
68. Weickert C.S., Straub R.E., McClintock B.W., Matsumoto M., Hashimoto R., Hyde T.M., Herman M.M., Weinberger D.R., and Kleinman J.E. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch. Gen. Psychiatry 61 (2004) 544-555
69. Whitney C., Weis S., Krings T., Huber W., and Kircher T. Task-dependent modulations of prefrontal and hippocampal activity during intrinsic word production. J. Cogn. Neurosci. 21 (2009) 697-712
70. Wildgruber D., Riecker A., Hertrich I., Erb M., Grodd W., Ethofer T., and Ackermann H. Identification of emotional intonation evaluated by fMRI. Neuroimage 24 (2005) 1233-1241
71. Williams N.M., O Donovan M.C., and Owen M.J. Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia?. Schizophr. Bull. 31 (2005) 800-805
72. Yamasue H., Iwanami A., Hirayasu Y., Yamada H., Abe O., Kuroki N., Fukuda R., Tsujii K., Aoki S., Ohtomo K., Kato N., and Kasai K. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study. Psychiatry Res. 131 (2004) 195-207
73. Yurgelun-Todd D.A., Waternaux C.M., Cohen B.M., Gruber S.A., English C.D., and Renshaw P.F. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am. J. Psychiatry 153 (1996) 200-205
74. Zinkstok J.R., de Wilde O., van Amelsvoort T.A., Tanck M.W., Baas F., and Linszen D.H. Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings. Behav. Brain Funct. 3 (2007) 19